CEVA director exercises options, nets 5,669 shares

CEVA director Peter McManamon reported routine equity compensation transactions.

Rhea-AI Filing Summary

CEVA director Peter McManamon reported routine equity compensation transactions. He exercised stock options covering 14,000 shares of common stock at $27.17 per share and, through a net-exercise, received 5,669 shares while 8,331 shares were withheld to cover the option exercise cost based on a market price of $45.66. After these transactions, he holds 57,494 common shares directly, including 50,938 shares outstanding and 6,556 unvested RSUs, and 272,085 shares indirectly through Shariva Limited Partnership. No open-market purchases or sales were reported.

Insider Trade Summary

14,000 shares exercised/converted

Exercise 4 txns

Insider MCMANAMON PETER

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	14,000	$27.17	$380K
Exercise	Common Stock	14,000	$27.17	$380K
Exercise Price or Tax Liability	Common Stock	8,331	$45.66	$380K
Grant/Award	Common Stock	0	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 57,494 shares (Direct); Common Stock — 272,085 shares (Indirect, By Shariva Limited Partnership)

Footnotes (3)

1. F1. Represents a net-exercise of outstanding stock options. The reporting person received 5,669 shares of common stock on the net exercise of an option to purchase 14,000 shares of common stock. The reporting person forfeited 8,331 shares of common stock underlying the option in payment of the exercise price, based on the market price of Ceva common stock at the time of the option exercise.
2. F2. Represents 50,938 shares outstanding and 6,556 unvested RSU's.
3. F3. The stock option became exercisable as to 25% of the underlying shares on 07/01/2017, the first year anniversary of the grant date, and 25% each year thereafter.

Key Figures

Options exercised: 14,000 shares Exercise price: $27.17/share Shares withheld: 8,331 shares +4 more

7 metrics

Options exercised 14,000 shares Common stock options exercised on 2026-06-09

Exercise price $27.17/share Stock option (Right to Buy) conversion price

Shares withheld 8,331 shares Used to pay option exercise cost at $45.66

Net shares received 5,669 shares Net-exercise of 14,000-share option grant

Direct common shares after 57,494 shares Post-transaction direct holdings

Indirect common shares 272,085 shares Held by Shariva Limited Partnership

Unvested RSUs 6,556 units Included within direct equity position

Key Terms

net-exercise, RSU, Stock Option (Right to Buy), tax liability

4 terms

net-exercise financial

"Represents a net-exercise of outstanding stock options."

RSU financial

"Represents 50,938 shares outstanding and 6,556 unvested RSU's."

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

tax liability financial

"Payment of exercise price or tax liability by delivering securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CEVA (CEVA) director Peter McManamon report in this Form 4?

He reported a routine option exercise and related share withholding. McManamon exercised options for 14,000 CEVA shares and received 5,669 net shares after 8,331 shares were used to cover the option exercise cost.

How many CEVA (CEVA) stock options did Peter McManamon exercise?

He exercised stock options on 14,000 CEVA common shares. The options had an exercise price of $27.17 per share and were fully exercised, leaving no remaining options under that specific grant after the reported transaction.

Were any of Peter McManamon’s CEVA (CEVA) transactions open-market sales or buys?

No open-market purchases or sales were reported. The Form 4 shows a stock option exercise and a share disposition classified as tax-related withholding, used to pay the option exercise cost, not a discretionary market trade.

How many CEVA (CEVA) shares does Peter McManamon own directly after the transaction?

He directly holds 57,494 CEVA common shares after the transaction. This total includes 50,938 shares outstanding and 6,556 unvested restricted stock units, as disclosed in the filing’s footnote description of his direct equity position.

What is Shariva Limited Partnership’s role in Peter McManamon’s CEVA (CEVA) holdings?

Shariva Limited Partnership holds 272,085 CEVA common shares attributed to McManamon as indirect ownership. The Form 4 identifies these shares as held “By Shariva Limited Partnership,” distinguishing them from his directly held CEVA equity.

What price was used for the CEVA (CEVA) shares withheld in the tax-related disposition?

The filing states that 8,331 CEVA shares were forfeited based on a market price of $45.66. These shares were used in a net-exercise structure to pay the option exercise cost rather than being sold in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCMANAMON PETER

(Last) (First) (Middle)

CEVA, INC.

15245 SHADY GROVE ROAD, SUITE 400

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEVA INC [ CEVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		M		14,000	A	$27.17	65,825	D
Common Stock	06/09/2026		F(1)		8,331	D	$45.66	57,494(2)	D
Common Stock	06/09/2026		A		0	A	$0	272,085	I	By Shariva Limited Partnership

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$27.17	06/09/2026		M			14,000	07/01/2017(3)	07/01/2026	Common Stock	14,000	$27.17	0	D

Explanation of Responses:

1. Represents a net-exercise of outstanding stock options. The reporting person received 5,669 shares of common stock on the net exercise of an option to purchase 14,000 shares of common stock. The reporting person forfeited 8,331 shares of common stock underlying the option in payment of the exercise price, based on the market price of Ceva common stock at the time of the option exercise.

2. Represents 50,938 shares outstanding and 6,556 unvested RSU's.

3. The stock option became exercisable as to 25% of the underlying shares on 07/01/2017, the first year anniversary of the grant date, and 25% each year thereafter.

	/s/ Peter McManamon	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)